Keertan Dheda

Keertan Dheda MBBCh (Wits), FCP(SA), FCCP, PhD (Lond), FRCP (Lond), born in March 1969, is a Professor of Respiratory Medicine, and Head of the Division of Pulmonology at the University of Cape Town, which provides tertiary respiratory facilities to a population of 3.74 million people including for poverty-related diseases such as tuberculosis, HIV, pneumonia, and other diseases including COPD, asthma and lung cancer. He holds a Professor of Mycobacteriology appointment at the London School of Hygiene and Tropical Medicine, and is a Visiting Professor at University College London. He is a South African National Research Foundation A-rated scientist.[1]

Keertan Dheda
BornMarch 1969
Durban, South Africa
NationalitySouth African, British
OccupationResearcher; Professor; Medical Doctor
Known forProfessor of Respiratory Medicine; Scientific contributions to the field of TB and Respiratory Medicine
Academic background
Alma materUniversity of Witwatersrand, University College London,
Academic work
DisciplineMedicine
Sub-disciplineRespiratory Medicine; Immunology; Antimicrobial Resistance; Tuberculosis
InstitutionsUniversity of Cape Town, University College of London, London School of Hygiene and Tropical Medicine

Research

His research work focuses on the molecular epidemiology, diagnosis, transmission, and treatment of TB, and antimicrobial resistance of pulmonary pathogens including Mycobacterium tuberculosis.[2] He has a keen interest in medical education and interventional pulmonology including bronchial thermoplasty, ultrasound-guided mediastinal biopsy (EBUS TBNA) and medical thoracoscopy.

Awards & recognition

He has been the recipient of several prestigious international awards including the International Union Against Tuberculosis and Lung Disease Scientific Award,[3] and the 2018 European Union-funded EDCTP Scientific Leadership Award.[4] Other awards include the Harry Oppenheimer Fellowship Award, the NSTF BHP-Billiton Research award,[5] MRC Scientific Achievement Award (Gold). He has been profiled in The Lancet,[6] the Business Day newspaper,[7] IOL,[8] News24,[9] and Carte Blanche, a high-profile news programme in South Africa.

Leadership

He serves on the editorial board of the journals PLoS One, American Journal of Respiratory and Critical Medicine, Lancet Respiratory Diseases and Scientific Reports, amongst others. He serves on several national and international academic and advisory bodies and holds 5 patents. He is the current President of the South African Thoracic Society,[10] and is the founder and co-director of the charity, Free of TB,[11] which provides support and healthcare to poor and needy persons afflicted with TB.

See also

References
  1. Dheda, Keertan. "NRF A rated scientist". uct.ac.za. University of Cape Town. Retrieved 29 May 2018.
  2. Dheda, Keertan. "Research work". lunginstitute.co.za. University of Cape Town Lung Institute. Retrieved 29 May 2018.
  3. "The Union Scientific Prize". The Union. Retrieved 2018-07-06.
  4. "UCT's leading TB researcher receives top international science prize".
  5. "NSTF Winners Press Release" (PDF).
  6. Dheda, Keertan (2014). "Rising star of pulmonology". The Lancet. 383 (9915): 403. doi:10.1016/S0140-6736(14)60140-9. PMID 24485575. Retrieved 29 May 2018.
  7. Dheda, Keertan. "Man on a mission". Pressreader.com. Press Reader. Retrieved 29 May 2018.
  8. "UCT to spearhead research into antibiotic resistance | Cape Times". Retrieved 2018-07-05.
  9. "TB bomb set to expolde". News24. Retrieved 2018-07-05.
  10. Dheda, Keertan. "President of South African Thoracic Society". pulmonology.co.za. South African Thoracic Society. Retrieved 29 May 2018.
  11. Dheda, Keertan. "Director and founder of Free of TB charity". freeoftb.com. Free of TB. Retrieved 29 May 2018.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.